Cargando…
WHO international non-proprietary names: the need to distinguish COVID-19 vaccines
Autores principales: | Loizides, Ursula, Adisa, Akinola, de la Rica Manjavacas, Ana López, Robertson, James S, Balocco, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906625/ https://www.ncbi.nlm.nih.gov/pubmed/33549168 http://dx.doi.org/10.1016/S0140-6736(21)00099-4 |
Ejemplares similares
-
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety
por: Robertson, James S., et al.
Publicado: (2022) -
The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough
por: Loizides, Ursula, et al.
Publicado: (2021) -
Curation of an international drug proprietary names dataset
por: Khaleel, Mohammad A., et al.
Publicado: (2021) -
A distinct name is needed for the new coronavirus
por: Jiang, Shibo, et al.
Publicado: (2020) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)